Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2023 Sep 15;234:106399. doi: 10.1016/j.jsbmb.2023.106399

Figure 4. Activation of the PDGFR/JAK/STAT/Fos/Jun pathway in endometrial cancer predicts for worse survival.

Figure 4.

Cases were separated into quartiles based on expression of PDGFRA, STAT1, STAT2, STAT3, STAT4, STAT6, FOS, JUN, JUNB and JUND. Kaplan-Meier Curve for the survival analysis was conducted on the highest and lowest quartiles using the AESA method.